A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass Jessica P. Simons, MD, MPH, Philip P. Goodney, MD, MS, Julie Flahive, MS, Andrew W. Hoel, MD, John W. Hallett, MD, Larry W. Kraiss, MD, Andres Schanzer, MD Journal of Vascular Surgery Volume 63, Issue 4, Pages 990-997 (April 2016) DOI: 10.1016/j.jvs.2015.09.051 Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 1 Kaplan-Meier curve shows amputation-free survival (AFS) of 74% at 1 year (N = 7750). Journal of Vascular Surgery 2016 63, 990-997DOI: (10.1016/j.jvs.2015.09.051) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 2 Kaplan-Meier curve shows amputation-free survival (AFS) over 1 year, stratified by modified Project of Ex-vivo vein graft Engineering via Transfection III (mPIII) risk group (n = 7737). Journal of Vascular Surgery 2016 63, 990-997DOI: (10.1016/j.jvs.2015.09.051) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 3 Kaplan-Meier curve shows for amputation-free survival (AFS) over 1 year, stratified by the Finland National Vascular (FINNVASC) registry risk score (n = 7738). Journal of Vascular Surgery 2016 63, 990-997DOI: (10.1016/j.jvs.2015.09.051) Copyright © 2016 Society for Vascular Surgery Terms and Conditions